| | | Single nucleotide variant (nonsense) | Malignant tumor of prostate +12 more | |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +11 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +11 more | GConflicting classifications of pathogenicity |
| | | Duplication | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | CHEK2-Related Cancer Susceptibility +11 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant) | Colorectal cancer +19 more | |
| | | Single nucleotide variant (missense variant +2 more) | Familial cancer of breast +6 more | |
| | | Single nucleotide variant (missense variant +2 more) | not specified +14 more | GConflicting classifications of pathogenicity; risk factor |
| | | Single nucleotide variant (missense variant +1 more) | Li-Fraumeni syndrome 2 +14 more | GPathogenic/Likely pathogenic |